LncRNA Inhibits the Viability of Triple-Negative Breast Cancer (TNBC) by Targeting the miR-330-5p/BCL2L2 Axis
Preprint in Research Square (March 2024)
The most recent citing publications are shown below. View all 28 publications that cite this research output on Dimensions.
Non-coding RNAs as therapeutic targets in cancer and its clinical application
Article in Journal of Pharmaceutical Analysis (February 2024)
Curcumin in treatment of hematological cancers: Promises and challenges
Article in Journal of Traditional and Complementary Medicine (January 2024)